Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 158

1.

Did death certificates and a death review process agree on lung cancer cause of death in the National Lung Screening Trial?

Marcus PM, Doria-Rose VP, Gareen IF, Brewer B, Clingan K, Keating K, Rosenbaum J, Rozjabek HM, Rathmell J, Sicks J, Miller AB.

Clin Trials. 2016 Mar 22. pii: 1740774516638345. [Epub ahead of print]

PMID:
27006427
2.

Editorial: The Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial: The Operations Behind a Herculean Task.

Marcus PM.

Rev Recent Clin Trials. 2015;10(3):172. No abstract available.

PMID:
26435287
3.

Participants' Views of Retention Materials Used in the PLCO Cancer Screening Trial.

Pretzel SM, Andrews TS, Broski K, Childs JC, Gren LH, Ogden SL, Mabie J, Thomas B, Rozjabek HM, Marcus PM.

Clin Med Res. 2015 Dec;13(3-4):139-48. doi: 10.3121/cmr.2015.1274. Epub 2015 Sep 20.

4.

Building Successful Relationships in the PLCO Cancer Screening Trial.

Marcus PM, Broski KG, Buys SS, Childs J, Church TR, Gohagan JK, Gren LH, Higgins D, Jaggi R, Jenkins V, Johnson CC, Lappe K, O'Brien B, Ogden SL, Prorok PC, Reding D, Shambaugh V, Yokochi LA, Yurgalevitch S.

Rev Recent Clin Trials. 2015;10(3):181-6.

PMID:
26238208
5.

Lessons in Medical Record Abstraction from the Prostate, Lung, Colorectal, and Ovarian (PLCO) National Screening Trial.

Bazzi L, Lamerato LE, Varner J, Shambaugh VL, Cordes JE, Ragard LR, Marcus PM.

Rev Recent Clin Trials. 2015;10(3):200-5.

PMID:
26238207
6.

Validation of Self-Report of Chest X-Ray Exam at a Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Center.

Gren LH, Lamerato LE, Wright P, Marcus PM.

Rev Recent Clin Trials. 2015;10(3):194-9.

PMID:
26238206
7.

Data Processing and Analytic Support in the PLCO Cancer Screening Trial.

Mabie J, Riley T, Marcus PM, Black A, Rozjabek H, Yu K, Young M, Austin J, Rathmell J, Williams C, Prorok PC.

Rev Recent Clin Trials. 2015;10(3):233-7.

PMID:
26238116
8.

Targeted Cancer Screening in Average-Risk Individuals.

Marcus PM, Freedman AN, Khoury MJ.

Am J Prev Med. 2015 Nov;49(5):765-71. doi: 10.1016/j.amepre.2015.04.030. Epub 2015 Jul 10.

9.

Lung cancer screening with low dose computed tomography (LDCT): looking back and moving forward.

Marcus PM.

Ann Transl Med. 2015 May;3(Suppl 1):S41. doi: 10.3978/j.issn.2305-5839.2015.03.36. No abstract available.

10.

Cancer screening and diagnosis: opportunities for smoking cessation intervention.

Land SR, Marcus PM.

J Clin Oncol. 2015 May 20;33(15):1631-2. doi: 10.1200/JCO.2015.61.2077. Epub 2015 Apr 20. No abstract available.

PMID:
25897157
11.

Occurrence of Distal Colorectal Neoplasia Among Whites and Blacks Following Negative Flexible Sigmoidoscopy: An Analysis of PLCO Trial.

Laiyemo AO, Doubeni C, Pinsky PF, Doria-Rose VP, Bresalier R, Hickey T, Riley T, Church TR, Weissfeld J, Schoen RE, Marcus PM, Prorok PC.

J Gen Intern Med. 2015 Oct;30(10):1447-53. doi: 10.1007/s11606-015-3297-3. Epub 2015 Apr 3.

PMID:
25835747
12.

Conceptualizing overdiagnosis in cancer screening.

Marcus PM, Prorok PC, Miller AB, DeVoto EJ, Kramer BS.

J Natl Cancer Inst. 2015 Feb 6;107(4). pii: djv014. doi: 10.1093/jnci/djv014. Print 2015 Apr.

13.

Interval lung cancers not detected on screening chest X-rays: How are they different?

Kvale PA, Johnson CC, Tammem├Ągi M, Marcus PM, Zylak CJ, Spizarny DL, Hocking W, Oken M, Commins J, Ragard L, Hu P, Berg C, Prorok P.

Lung Cancer. 2014 Oct;86(1):41-6. doi: 10.1016/j.lungcan.2014.07.013. Epub 2014 Jul 24.

14.

Non-compliance with the initial screening exam visit in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.

Marcus PM, Ogden SL, Gren LH, Childs JC, Pretzel SM, Lamerato LE, Walsh K, Rozjabek HM, Mabie J, Thomas B, Riley T.

Prev Med. 2014 Oct;67:82-8. doi: 10.1016/j.ypmed.2014.07.013. Epub 2014 Jul 16.

15.

Estimating overdiagnosis in lung cancer screening.

Marcus PM.

JAMA Intern Med. 2014 Jul;174(7):1198. doi: 10.1001/jamainternmed.2014.1546. No abstract available.

PMID:
25003884
16.

Results of the two incidence screenings in the National Lung Screening Trial.

Aberle DR, DeMello S, Berg CD, Black WC, Brewer B, Church TR, Clingan KL, Duan F, Fagerstrom RM, Gareen IF, Gatsonis CA, Gierada DS, Jain A, Jones GC, Mahon I, Marcus PM, Rathmell JM, Sicks J; National Lung Screening Trial Research Team.

N Engl J Med. 2013 Sep 5;369(10):920-31. doi: 10.1056/NEJMoa1208962.

17.

Culturally sensitive approaches to recruitment and retention of Hispanics in the national lung screening trial.

Tenorio SL, O'Donnell CI, Hernandez J, Rozjabek HM, Lynch D, Marcus PM.

J Immigr Minor Health. 2014 Aug;16(4):761-4. doi: 10.1007/s10903-013-9862-0.

PMID:
23780349
18.

Results of initial low-dose computed tomographic screening for lung cancer.

National Lung Screening Trial Research Team, Church TR, Black WC, Aberle DR, Berg CD, Clingan KL, Duan F, Fagerstrom RM, Gareen IF, Gierada DS, Jones GC, Mahon I, Marcus PM, Sicks JD, Jain A, Baum S.

N Engl J Med. 2013 May 23;368(21):1980-91. doi: 10.1056/NEJMoa1209120.

19.

Factors associated with the risk of adenoma recurrence in distal and proximal colon.

Laiyemo AO, Doubeni C, Pinsky PF, Doria-Rose VP, Marcus PM, Schoen RE, Lanza E, Cross AJ.

Digestion. 2013;87(3):141-6. doi: 10.1159/000346281. Epub 2013 Mar 15.

20.

Obesity, weight change, and risk of adenoma recurrence: a prospective trial.

Laiyemo AO, Doubeni C, Badurdeen DS, Murphy G, Marcus PM, Schoen RE, Lanza E, Smoot DT, Cross AJ.

Endoscopy. 2012 Sep;44(9):813-8. doi: 10.1055/s-0032-1309837. Epub 2012 Aug 27.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk